These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9259911)

  • 1. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.
    Seto A; Einarson T; Koren G
    Am J Perinatol; 1997 Mar; 14(3):119-24. PubMed ID: 9259911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
    Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
    Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis.
    Gutzin SJ; Kozer E; Magee LA; Feig DS; Koren G
    Can J Clin Pharmacol; 2003; 10(4):179-83. PubMed ID: 14712322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis.
    Etwel F; Faught LH; Rieder MJ; Koren G
    Drug Saf; 2017 Feb; 40(2):121-132. PubMed ID: 27878468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of quinolones--a meta-analysis of pregnancy outcomes.
    Bar-Oz B; Moretti ME; Boskovic R; O'Brien L; Koren G
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):75-8. PubMed ID: 19181435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome following exposure to permethrin and use of teratogen information.
    Kennedy D; Hurst V; Konradsdottir E; Einarson A
    Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis.
    Kozer E; Costei AM; Boskovic R; Nulman I; Nikfar S; Koren G
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):70-84. PubMed ID: 12852485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester disulfiram exposure: report of two cases.
    Helmbrecht GD; Hoskins IA
    Am J Perinatol; 1993 Jan; 10(1):5-7. PubMed ID: 8442800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistamines are safe during the first trimester.
    Koren G
    Can Fam Physician; 1997 Jan; 43():33-4. PubMed ID: 9626418
    [No Abstract]   [Full Text] [Related]  

  • 13. Bupropion in pregnancy and the prevalence of congenital malformations.
    Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-trimester exposure to alprazolam.
    St Clair SM; Schirmer RG
    Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
    Walfisch A; Al-maawali A; Moretti ME; Nickel C; Koren G
    J Obstet Gynaecol; 2011 Aug; 31(6):465-72. PubMed ID: 21823839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
    Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
    J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
    Diav-Citrin O; Okotore B; Lucarelli K; Koren G
    Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of chemical and physical factors in the work environment on the amount of risk for abnormal pregnancy outcome].
    Makowiec-Dabrowska T; Radwan-Włodarczyk Z; Koszada-Włodarczyk W; Siedlecka J; Wilczyński J
    Med Pr; 1997; 48(3):239-59. PubMed ID: 9312650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.